Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Cardiovascular risks in hemophilia A

Humphries TJ et al. Adv Med Sci. 2018;63(2):329-33

Key clinical point: Concerns may be unfounded about risks of earlier-onset cardiovascular disease in men with hemophilia A.

Major finding: Prevalence rates of diabetes (P = .0108) and hyperlipidemia (P = .0001) were higher in the control group, compared with patients with hemophilia A.

Study details: A retrospective chart review involving 74 men with hemophilia A and 222 men without the condition, matched by study year, payer type, race, and age.

Disclosures: The study was funded by Bayer. Three authors were employed by Bayer when the study was conducted. Other authors reported employment by Xcenda and the Henry Ford Health System and research funding from Xcenda.

Read the article here.

Citation:

Humphries TJ et al. Adv Med Sci. 2018;63(2):329-33.

This Week's Must Reads

Immune system changes play a role in AML relapse, Christopher MJ et al. N Engl J Med. 2018 Oct 31. doi: 10.1056/NEJMoa1808777.

Haploidentical allo-HCT possible even in relapsed myeloma, Sahebi F, et al. Biol Blood Marrow Transplant. 2018 Sep 20. pii: S1083-8791(18)30575-5.

Venetoclax plus HMA studied in AML, DiNardo C et al. Blood. 2018 Oct 25. doi: 10.1182/blood-2018-08-868752.

The role of PTPN22 R620W in CLL, Leukemia & Lymphoma 2018

Must Reads in Bleeding Disorders

Systematic review examines sickle cell trait complications, Naik RP et al. Ann Intern Med. 2018 Oct 30. doi:10.7326/M18-1161

Cardiovascular risks in hemophilia A, Humphries TJ et al. Adv Med Sci. 2018;63(2):329-33

Study evaluates rapid bacterial testing of platelets, Booth AL et al. AABB18, Abstract INV4

ISTH-BAT is predictive in hemophilia A and B, Borhany M et al. Transfus Apher Sci. 2018 Aug;57(4):556-60

Restricted platelet transfusion yields better outcomes in preterm infants, Curley A et al. N Engl J Med. 2018 Nov 2. doi: 10.1056/NEJMoa1807320